This is an outdated version published on 2022-03-15. Read the most recent version.

Clinical correlation of CC screening using Pap smear test

Authors

  • Yasamin Hamza Sharif a:1:{s:5:"en_US";s:26:"University of Al-Qadisiyah";}

DOI:

https://doi.org/10.47750/jptcp.2022.892

Keywords:

Cervical Pap smear, abnormal smear, Human papilloma virus, PCR.

Abstract

Abstract

Background and objectives: The cervical cancer (CC) has its long pre-invasive stage, which allows for a preventive detection and possible cure. In this study, this stage was a target stage to investigate women with precancerous lesions by applying the Papanicolaou (Pap) smear test and perform a correlation study.

Patients and methods: A two-year cross sectional study was conducted, in which 200 married women (21-60 years old) were participated in the investigation, which included women with Pap-test abnormal results (atypical squamous cells of undetermined significance (ASCUS), low-grade squamous intraepithelial lesion (LSIL), and high-grade squamous intraepithelial lesions (HSIL)), which were sent to perform a polymerase chain reaction (PCR) test to detect the presence of human papillomavirus (HPV) of (6 and 11), a low-risk type, and (16 and 18), a high-risk type, with colposcopy examination and colposcopy-guided biopsy, if needed for women with abnormal colposcopy outcomes. The treatment, per severity and disease stage, was applied.

Results: The clinical presentation and pap smear results of women enrolled in the study were asymptomatic 82.5%, postcoital bleeding (PCB) was seen in (17.0 %) and intermenstrual bleeding (IMB) was seen in a single case (0.5 %). History of sexually transmitted diseases (STD) was seen in (2.5 %). Pap smear results were as following: No remarkable pathology seen in (36.0 %), Inflammatory evidence seen in (32.0 %), ASCUS was seen in (19.0 %), LSIL seen in (7.5 %) and HSIL seen in (5.5 %). Regarding human papilloma virus infection was negative in (95.0 %), low risk virus strains were seen in (1.5 %) and high risk viruses were seen in (3.5 %). Low risk HPV included 6, 11 and 42, whereas, high risk group included 5 cases of HPV16 and 2 cases of HPV 18.

Conclusions: The present work presents the Pap smear test as a highly useful, easy, technically safe, and cost-effective tool for detecting the cervical epithelial precancerous lesions, which can be used as a routine screening technique for better treatment outcomes and reducing mortality rates. The power of detection of these lesions can be potentiated when using the Pap test and HPV-PCR test together.

References

References

-Ferlay J ,Soerjomataram I, Dikshit R , et al. Cancer incidence and mortality worldwide: Sources , methods and major patterns in GLOBOCAN.Int J Cncer.2015;136:359-86.

-Rosai J.Ackerman´s Surgical Pathology.2011;10th ed:1447.

-Sreedevi A, Javed R ,and Dinesh A .Epidemiology of CC with special focus on India. Int J Women Health.2015;7;405-414.

-Jinan J Al-Mussawy , Abdul-Hssein M Al-Faisal , Saif D Al-Ahmer, et al .Cervical abnormalities and cancer incidence in some Iraqi married women. Iraqi J Biotechnology .2019;18:58-66.

-Jafari Shobeiri M , Halimi M,Dastranj A , et al .Screening for CC and precancerous lesions in Tabriz .MJIRI.2007;21:1-10.

-Bal MS ,Goyal R,Suri AK , et al. Detection of abnormal cervical cytology in Paoanicolauu smear.JCytol.2012;29:45-47.

-Patel MM,Pandya AN ,Modi J. Cervical Pap smear study and its utility in cancer screening to specify the strategy for CC control. Natl J Community Med.2011;2:49-51.

-Jonathan S and Berek MA .Novak´s Gynecology(15th ed) united states of America.Lippincott Williams and Wiikins.2012;1305.

-Santin AD , Zhan F , Bignotti E , et al .Gene expression profiles of primary HPV 16 and HPV 18 infected early stage CCs and normal cervical epithelium.Virology.2005;331:269-291.

-Idestorm M,Milsom I, Andersson-ellstorm A.Knowledge and attitudes about the Pap-smear screening programme:a population based study of women aged 20-59 years .Acta Obstet Gynecol Scand .2002;81:962-970.

-Herrington S and Ghobashy AE. CC:epidemiology and molecular characterization .Progress in Obesterics and Gynecology .16th ed.2005:323-341.

-Burd EM. Human papilloma virus and CC.Clin Microbiol Rev.2003;8:1-17.

-Nayar R,Wilbur DC.The Bethesda system for reporting cervical cytology: definitions ,criteria , and explanatory notes. 2015;3rd ed.

-Nayir T,Okyay AR,Nizlican E, et al. CC screening and early diagnoses and screening center in Mersin,Turky.Asian Pac J Cancer Prev.2015;16:6909-12.

-Maleki A ,Ahmadina E,Avazeh A ,et al. Prevalence of abnormal pap test results and related factors among women living in Zanjan , Iran. Asian Pac J Cancer Prev.2015;16:6935-9.

-Cyrus-David M.S ,Michielitte R,Paskett ED, et al. CC risk as a predictor of Pap smear use in rural North Carolina .J Rural Health.2002:18:67-76.

-Atilgan R,Celik A,Boztosum A , et al. Evaluation of cervical cytology abnormalities in Turkish population. Indian J Pathol Microbiol.2012;55:52-55.

-Kulkarni PR,Rani H, Vimalambike M G , et al. Opportunistic screening for CC in a tertiary hospital in Karntaka , India.Asian Pac J Cancer Prev .2013 ;14:5101-5.

-Bhitia K , Puri M, Gami N , et al .Persistent inflammation on Pap smear :Does it warrant evaluation ? Indian J Cancer.2011;48:220-2.

-Barouti E,Farzaneh F,Sene A .The pathogenic micro-organism in pap vaginal smears and correlation with inflammation. J Family Reproductive Health.2013;7:23-27.

-Verma A , Verma s ,Vashist S , ET AL.a study on CC screening in symptomatic women using pap smear in tertiary care hospital in rural area of Himachal Predesh , I ndia.Middel East Fertil Soc J.2017;22:39-42.

-Pamini CP ,Indira N ,Chaitra R , ET AL .Cytological and colposcopic evaluation of unhealthy cervix. J Evid Med Health.2015;2:6920-7.

-Nayani Z S ,Hendre P C .Comparisom and correlation of Pap smear with colposcopy and histopathology in evaluation of cervix.J Evol Med Dent Sci.2015;4:9236-47.

-Magdy H B ,Mohammed S M ,Naema G , et al .Cytological pattern of cervical pap smear in eastern region of Saudi Arabia .J Cytol .2011;28:1737-7.

-Saha D , Ghosh S ,Nath S , et al. Utility of Pap smear screening for prevention of CC . A 3 years study from rural Tripura –India. Int J Med and Dent Sci.2017;6:1456-61.

-Green J ,De Gonzalez A B ,Smith J , et al.Human papilloma virus infection and use of oral contraceptions. Br J Cancer.2003;88:1713-1720.

-Gayed M ,Bernatsky S ,Ramsey – Goldman R, et al. Lupus and Cancer .Lupus.2009;18:479-485.

- Rachel Siqueira, Emmanuele P. and ortrud M. prevalence of high risk Human papillomavirus genotypes and predicators factors for CC in Brazilian women without cytological abnormalities. Adv Bioteh Micro. 2018; 8: 1-5.

- Gnerry SL, Rosa CJ, Markowitz LE, et al. Human papillomavirus vaccine initiation among adolescent girls in high risk communities vaccine. 2011; 29: 2235-2241.

-Swangvaree S.S., Kongkaew P., Ngamkham J. frequency and type – distribution of HPV from paraffin – embedded blocks of high grade cervical intraepithelial neoplasia lesions in Thailand. Ascian pac J cancer prev. 2013; 14: 1023 - 1026.

-Sukvirach S., Smith J.S, Tunsakul S, et al. population based HPV prevalence in Thailand. J infect Dis. 2003; 187; 1246-1256.

-Siriaunkgul S, Settakorn J, Sukpan K, et al. HPV detection and genotyping in Vulvar squamous cell carciroma in Thialand. Ascian pac J cancer prev. 2014; 15: 3773 – 3780.

-Solomon D, Schiffman M, and Tarone R. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance journal of the national cancer institute. 2001; 93: 293-299.

Published

2022-03-15

Versions

How to Cite

Yasamin Hamza Sharif. (2022). Clinical correlation of CC screening using Pap smear test. Journal of Population Therapeutics and Clinical Pharmacology, 29(01). https://doi.org/10.47750/jptcp.2022.892
More Citation Formats

Issue

Section

Articles

How to Cite

Yasamin Hamza Sharif. (2022). Clinical correlation of CC screening using Pap smear test. Journal of Population Therapeutics and Clinical Pharmacology, 29(01). https://doi.org/10.47750/jptcp.2022.892